NovoCure (NVCR) Equity Average (2015 - 2026)
NovoCure recorded quarterly Equity Average of $335.6 million in Q1 2026, down 1.56% quarter-over-quarter from $340.9 million in Q4 2025, and down 7.06% year-over-year from $361.1 million in Q1 2025.
NovoCure's Equity Average history runs 12 years deep, the most recent figure standing at $335.6 million for Q1 2026.
- In Q1 2026, Equity Average fell 7.06% year-over-year to $335.6 million; the TTM figure through Mar 2026 stood at $335.6 million (down 7.06% YoY), while the FY2025 annual figure was $350.3 million, down 3.05% from the prior year.
- Equity Average came in at $335.6 million for Q1 2026 at NovoCure, down from $340.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $443.5 million in Q3 2022 to a low of $335.6 million in Q1 2026.
- A 5-year average of $386.7 million and a median of $361.3 million in 2024 frame the typical range for Equity Average.
- Across the five-year window, Equity Average increased 14.06% in 2022 and slipped 17.34% in 2024, its largest moves.
- NovoCure's Equity Average stood at $443.3 million in 2022, then dropped by 14.71% to $378.1 million in 2023, then decreased by 4.66% to $360.5 million in 2024, then retreated by 5.43% to $340.9 million in 2025, then fell by 1.56% to $335.6 million in 2026.
- According to Business Quant data, Equity Average over the past three periods registered $335.6 million, $340.9 million, and $345.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 335.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 335.59 Mn |
| Dec 31, 2025 | 340.90 Mn |
| Sep 30, 2025 | 345.39 Mn |
| Jun 30, 2025 | 355.70 Mn |
| Mar 31, 2025 | 361.07 Mn |
| Dec 31, 2024 | 360.48 Mn |
| Sep 30, 2024 | 361.27 Mn |
| Jun 30, 2024 | 360.55 Mn |
| Mar 31, 2024 | 360.93 Mn |
| Dec 31, 2023 | 378.10 Mn |
| Sep 30, 2023 | 404.69 Mn |
| Jun 30, 2023 | 423.91 Mn |
| Mar 31, 2023 | 436.66 Mn |
| Dec 31, 2022 | 443.29 Mn |
| Sep 30, 2022 | 443.54 Mn |
| Jun 30, 2022 | 438.78 Mn |
| Mar 31, 2022 | 423.19 Mn |
| Dec 31, 2021 | 411.83 Mn |
| Sep 30, 2021 | 405.22 Mn |
| Jun 30, 2021 | 384.70 Mn |
| Mar 31, 2021 | 424.33 Mn |
| Dec 31, 2020 | 391.78 Mn |
| Sep 30, 2020 | 287.43 Mn |
| Jun 30, 2020 | 254.89 Mn |
| Mar 31, 2020 | 229.87 Mn |
| Dec 31, 2019 | 204.08 Mn |
| Sep 30, 2019 | 174.64 Mn |
| Jun 30, 2019 | 142.65 Mn |
| Mar 31, 2019 | 119.33 Mn |
| Dec 31, 2018 | 113.60 Mn |
| Sep 30, 2018 | 113.51 Mn |
| Jun 30, 2018 | 109.10 Mn |
| Mar 31, 2018 | 109.84 Mn |
| Dec 31, 2017 | 115.12 Mn |
| Sep 30, 2017 | 117.12 Mn |
| Jun 30, 2017 | 123.22 Mn |
| Mar 31, 2017 | 135.62 Mn |
| Dec 31, 2016 | 150.29 Mn |
| Sep 30, 2016 | 172.44 Mn |
| Jun 30, 2016 | 203.54 Mn |
| Mar 31, 2016 | 235.62 Mn |
| Dec 31, 2015 | 186.02 Mn |